Do pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck?

dc.contributor.authorElsheikh, Mohamed Nasser
dc.contributor.authorFerlito, Alfio
dc.contributor.authorRinaldo, Alessandra
dc.contributor.authorShaha, Ashok R.
dc.contributor.authorKhafif, Avi
dc.contributor.authorKowalski, Luiz P.
dc.contributor.authorMedina, Jesus E.
dc.contributor.buuauthorCoşkun, H. Hakan
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Kulak Burun Boğaz-Baş Boyun Cerrahisi Anabilim Dalı.tr_TR
dc.contributor.scopusid13610800100tr_TR
dc.date.accessioned2021-12-03T09:32:47Z
dc.date.available2021-12-03T09:32:47Z
dc.date.issued2006-02
dc.description.abstractSince the first detailed description by Franciszek Jaw-dyn ́ski in 1888,1-4there have been many variations andmodifications of the radical neck dissection procedure.These include modified radical neck dissection (alsocalled functional neck dissection) and various selectiveneck dissections.5-6Analysis of the distribution of lymph node metastasesin patients with squamous carcinoma of the larynx re-veals a marked preference for levels II, III, and IV; levelsI and V are rarely involved.7-9Based on these observa-tions, lateral neck dissection has been recommended inpatients with necks staged as N0 or N1.10This meansremoving the upper jugular lymph nodes (level II), mid-dle jugular lymph nodes (level III), and lower jugularlymph nodes (level IV). Lateral neck dissection is alsodescribed as jugular node dissection by many surgeons.The need for routine dissection at level IV has re-cently been questioned.11This article discusses whethersparing level IV lymph nodes is justified on the strengthof pathologic and molecular studies on the pattern ofnodal metastasis in patients with squamous carcinomaof the larynx. In other words, dare we perform a selectiveneck dissection involving levels IIA and III for N0 necklaryngeal cancer to avoid potential complications such aschylous fistula or phrenic nerve injury?en_US
dc.identifier.citationElsheikh, M. N. vd. (2006). ''Do pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck?''. Journal of the American College of Surgeons, 202(2), 320-323.en_US
dc.identifier.endpage323tr_TR
dc.identifier.issn1072-7515
dc.identifier.issn1879-1190
dc.identifier.issue2tr_TR
dc.identifier.pubmed16427559tr_TR
dc.identifier.scopus2-s2.0-30944437392tr_TR
dc.identifier.startpage320tr_TR
dc.identifier.urihttps://doi.org/10.1016/j.jamcollsurg.2005.09.012
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S1072751505015164
dc.identifier.urihttp://hdl.handle.net/11452/22985
dc.identifier.volume202tr_TR
dc.identifier.wos000235154300018tr_TR
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherElsevieren_US
dc.relation.journalJournal of the American College of Surgeonsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectSurgeryen_US
dc.subjectCanceren_US
dc.subjectManagementen_US
dc.subjectCell carcinomaen_US
dc.subjectCervical node metastasesen_US
dc.subject.emtreeCytokeratin 20en_US
dc.subject.emtreeCytokeratin 19en_US
dc.subject.emtreeTissue preservationen_US
dc.subject.emtreeSquamous cell carcinomaen_US
dc.subject.emtreeReviewen_US
dc.subject.emtreeReverse transcription polymerase chain reactionen_US
dc.subject.emtreePriority journalen_US
dc.subject.emtreePhrenic nerveen_US
dc.subject.emtreeNerve injuryen_US
dc.subject.emtreeNeck dissectionen_US
dc.subject.emtreeLymph node metastasisen_US
dc.subject.emtreeLarynx carcinomaen_US
dc.subject.emtreeHumanen_US
dc.subject.emtreeHistopathologyen_US
dc.subject.emtreeCricoiden_US
dc.subject.emtreeChyleen_US
dc.subject.emtreeCancer stagingen_US
dc.subject.emtreeCancer incidenceen_US
dc.subject.meshNeoplasm stagingen_US
dc.subject.meshNeck dissectionen_US
dc.subject.meshLymphatic metastasisen_US
dc.subject.meshLaryngeal neoplasmsen_US
dc.subject.meshHumansen_US
dc.subject.meshCarcinoma, squamous cellen_US
dc.subject.scopusNeck Dissection; Tongue Neoplasms; Sentinel Lymph Node Biopsyen_US
dc.subject.wosSurgeryen_US
dc.titleDo pathologic and molecular analyses of neck dissection specimens justify the preservation of level IV for laryngeal squamous carcinoma with clinically negative neck?en_US
dc.typeReview
dc.wos.quartileQ1en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: